Explore strategies for payers to enhance collaboration with providers in value-based care through real-time data, EHR integration, and aligned incentives to improve patient outcomes and reduce healthcare costs.

Explore the complexities of choosing Medicare Advantage and other health plans in the U.S., including cost implications, emerging care models, and resources for diverse patient needs.

CMS and FDA have initiated the ACCESS Model and TEMPO pilot to expand technology-driven care for Medicare chronic condition patients, focusing on outcomes-based payments and regulatory flexibility.

CMS introduces the MAHA ELEVATE model, a voluntary payment program funding lifestyle medicine interventions not covered by Original Medicare to improve chronic disease prevention.

CMS launches the ACCESS Model, a 10-year initiative to enhance chronic disease management for Medicare beneficiaries through technology and outcome-based payments.

Explore the regulatory frameworks influencing data exchange in value-based care, including CMS rules, HIPAA, and state requirements. Understand operational challenges in healthcare data governance.

CMS introduces the MAHA ELEVATE Model to finance lifestyle and functional medicine interventions in Original Medicare, targeting chronic disease prevention and cost reduction.

CMS finalizes the mandatory Ambulatory Specialty Model in Medicare, expanding value-based care to specialists treating chronic conditions with two-sided financial risk and collaborative care requirements.

CMS and FDA introduce ACCESS and TEMPO models to enable digital health device integration in traditional Medicare, focusing on outcome-aligned payments, regulatory easing, and expanded patient access.

CMS's mandatory TEAM model starts in 2026, bundling payments for select procedures and increasing home health utilization. Key insights on risks, preparation, and hospital partnerships for providers.